Device Trial Radar · NCT05549453
Use of Nexstim SNBT System
Last checked: Nov 20, 2026Latest source record: Nov 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
Sep 26, 2022
Primary completion
Dec 31, 2022
Study completion Dec 31, 2023
Sponsor
- Lead sponsor
- Nexstim LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 22, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The clinical investigation assesses the usability of the new graphical user interface of the Nexstim SNBT device in its intended clinical uses. The hardware and the technical functionality of the device of the SNBT device are in other respects similar to those of the earlier Nexstim NBT device, which has been cleared by FDA for treatment of Major Depressive Disorder in 2017 (K170902) and has received EU CE mark for the same and for treatment of chronic neuropathic pain. The present investigation is not intended to establish the safety and efficacy of the SNBT device. Rather, the purpose is to assess the usability of the new user interface in a feasibility study conducted with a prototype device utilizing the new user interface.
Conditions
- Usability of the Graphical User Interface of the Device for Its Intended Use
Interventions
Nexstim SNBT useDevice
Active device use
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of usability of the graphical user interface for use of the device in its intended useTime frame: Up to 3 months. From subject's enrollment to end of subject's study participation.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nexstim Plc
Helsinki, Uusimaa, Finland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.